Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
biotech
boston blog main
boston top stories
fda
life sciences
national blog main
national top stories
2019
activism
acute hepatic porphyria
alexion pharmaceuticals
archive
bernie sanders
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
charges
clinical trials
congress
crisis
deals
detroit blog main
detroit top stories
dicerna pharamceuticals
drug prices
easl
fatty liver disease
givosiran
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
house of representatives
indiana blog main
indiana top stories
indivior
What
disease
3
×
drug
3
×
gene
3
×
approval
therapy
treat
administration
advanced
alnylam’s
approves
bff
bio
called
caught
causing
children
conference
deals
designed
devoted
dicerna
easl
eye
fda
food
form
genetic
hepatitis
infants
intended
issued
kicked
liver
major
medicines
pay
pharma
pharmaceuticals
producing
protein
Language
unset
Current search:
drug
×
disease
×
gene
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@slashgear.com
5 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
